Adrienne Blanchard's practice is focused on the interests of companies in life sciences, food, and consumer products, with an emphasis on IP, regulatory, and commercial matters.
Ms. Blanchard's experience includes three years with the federal government developing IP policy, and private practice, initially in an IP boutique, then in national and global law firms. Adrienne started her own practice in 2015.
In her trademarks practice Ms. Blanchard offers a range of services including clearance opinions for trademarks to be used in Canada, filing applications and opposition matters before the Trademarks Office.
In commercial and regulatory matters, Ms. Blanchard negotiates distribution agreements, licences, clinical trial and other agreements, and advises on regulatory compliance. She is an experienced advisor on matters of privacy compliance and defends against access to company information held by governments. She represents clients in various matters before regulatory bodies including Health Canada, the Patented Medicine Prices Review Board and the Canadian Food Inspection Agency.
Best Lawyers in Canada: Biotechnology Law (2021)
Global Elite Thought Leader, Who’s Who Legal, Life Sciences (2019-2020)
Chambers: Life Sciences, Canada: Recognized Practitioner (2018-2020)
Who’s Who Legal: Life Sciences Canada (2012 – 2020)
Lexpert: Leading Practitioner in Biotech and IP (2012 – 2019)
Registered Trademark Agent
Member of the Intellectual Property Institute of Canada
Member of BIOTECanada's Health Advisory Board
Update on Quebec Law, Bill 92, Toronto, 2017.
Moving Food Commodities across National Borders: Compliance, Tips, and Strategies, Washington DC, 2015.
The Right to be Forgotten: Privacy versus Access to Information in the Digital Age, Webinar, 2015.
U.S. and Canadian Proposed Nutrition Label Changes: Doing Business in Both Countries, Webinar, 2015.
Legal Issues for Biologics, Toronto, 2014.
Update on Legislative and Regulatory Environment, Montreal, 2014.
Navigating Canada’s Anti-Spam Law, Ottawa, 2014.
Transparency and the Use/Disclosure of Information Held by Health Canada, Vienna, 2014.
Pan-Canadian Drug Pricing Alliance; How Will It Unfold? Montreal, 2013.
Life Sciences Law in Canada, editor of and contributing author to text (Blanchard, A.) Thomson-Carswell, 2006 – 2020
Canada’s Patent Utility Regime on Trial, article, MLIP Newsletter, MacDonald-Laurier Institute, May 2016
Evolution of drug reimbursement in Canada: the Pan-Canadian Pharmaceutical Alliance for New Drugs, co-author of article (Husereau D., Dempster W., Blanchard A., and Chambers, J.), Value Health, December 2014
Amendments to the Canadian Trademarks Act are Coming: What Trademark Owners Should Do, article, Pharma in Brief, October 20, 2014
Update on Canadian Internet Pharmacy Issues, article, Food and Drug Law Institute, Update Magazine, May/June 2014
Food Law in Canada: Looking Forward to 2014, co-author of article (Healey, M. and Blanchard, A.), Food and Drug Law Institute, Update Magazine, March/April 2014
Will a pan-Canadian approach to drug purchasing save the provinces money?, co-author of article (Dempster W., Blanchard A., and Chambers, J.), Macdonald-Laurier Institute, Inside Policy, November 2013
Practical Guide to Intellectual Property Issues in the Pharmaceutical Industry, co-author of text (Blanchard, A., Steinberg, J., and Gill,K.) EIPR, 2007